Saturday 17 October 2026
Export KTTA’s income statement to Excel — free account
Pasithea Therapeutics Corp.
KTTA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 75.8% and free cash flow fell 21.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.42
0.01
+2.44%
Follow KTTA
| Dec '17 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | — | — | — |
Altman Z-Score |
— | — | 6.67 | 2.97 | — | — | — |
P/S ratio |
— | — | 0.00 | 33.35 | — | — | — |
P/FCF ratio |
— | — | 0.00 | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
— | — | 34.21 | 18.05 | — | — | — |
P/Operating CF |
— | — | (10.56) | (5.09) | — | — | — |
P/B ratio |
— | — | 0.36 | 0.38 | — | — | — |
Price to Tangible BV |
— | — | 0.36 | 0.50 | — | — | — |
EV/Sales |
— | — | 0.00 | (34.65) | — | — | — |
EV/EBITDA |
— | — | 7.64 | 1.34 | — | — | — |
EV/Operating CF |
— | — | 10.88 | 1.42 | — | — | — |
EV/FCF |
— | — | 10.81 | 1.40 | — | — | — |
Quick Ratio |
— | 36.92 | 118.41 | 17.62 | 6.20 | 6.18 | 11.11 |
Current Ratio |
— | 37.58 | 119.16 | 18.15 | 6.34 | 6.58 | 11.35 |
Net Debt/EBITDA |
— | 5.94 | 11.75 | 2.63 | 1.07 | 0.51 | 2.74 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.94 | 1.46 | 0.85 | 0.80 | 1.00 | 0.74 |
Capex/Depreciation |
— | — | (15.36) | (21.00) | 0.12 | 0.00 | 0.02 |
Interest Coverage |
— | — | (9,014.80) | (125,890.00) | — | — | — |
| — | (0.16%) | (8.41%) | (29.68%) | (48.44%) | (72.83%) | (58.36%) | |
| — | (33.06%) | (8.11%) | (28.30%) | (44.78%) | (65.93%) | (53.54%) | |
ROIC |
— | 0.00% | 0.00% | (83.61%) | (141.31%) | (113.31%) | 0.00% |
Return on Tangible Assets |
— | (16.98%) | (4.11%) | (43.11%) | (112.41%) | (218.26%) | (39.68%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 29,835.76% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.22 | 0.35 | 0.53 | 0.06 |
Share Based Compensation of Revenue |
— | — | 8,088.08% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | 2.79 | 1.93 | — | — | — |
Graham Number |
— | — | 0.00 | 0.00 | — | — | — |
Earnings Yield |
— | — | (11.80%) | (85.87%) | — | — | — |
Free Cash Flow Yield |
— | — | (17.35%) | (73.95%) | — | — | — |
Revenue per Share |
— | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.11) | (6.10) | (9.43) | (10.44) | (12.70) | (2.16) |
Capex per Share |
— | 0.00 | (0.04) | (0.08) | 0.06 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (0.11) | (6.14) | (9.51) | (10.38) | (12.70) | (2.16) |
Cash per Share |
— | 0.66 | 101.80 | 26.22 | 13.31 | 6.32 | 7.86 |
Shareholders Equity per Share |
— | 0.66 | 98.83 | 33.68 | 19.07 | 13.49 | 7.85 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.66 | 98.83 | 33.68 | 19.07 | 13.49 | 7.85 |
Free Cash Flow |
— | (0.04) | (3.20) | (12.00) | (12.74) | (13.92) | (15.20) |
Working Capital |
— | 0.24 | 52.85 | 32.20 | 14.06 | 6.25 | 51.49 |
Capital Expenditures |
— | — | (0.02) | (0.11) | 0.08 | — | 0.01 |
Net Current Asset Value |
— | 0.24 | 51.40 | 31.39 | 13.97 | 6.09 | 51.44 |
EV/EBIT |
— | — | 7.66 | 1.34 | — | — | — |
Capex to Sales |
— | — | 1.42 | 0.00 | 0.00 | — | 0.00 |
Price to Operating Income |
— | — | 0.00 | 0.00 | — | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
— | — | 0.07 | 0.04 | 4.59 | 5.31 | 0.00 |
Cash ROIC |
— | (7.98%) | (3.06%) | (15.88%) | (32.06%) | (64.15%) | (13.76%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 0.00 | 9,437.25 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | — | — | — |
Average Payables |
— | 0.23 | 0.23 | 0.96 | 2.02 | 1.84 | 1.13 |
Average Assets |
— | 0.12 | 26.78 | 49.25 | 35.65 | 21.09 | 38.15 |
Average Common Equity |
— | 25.83 | 25.83 | 46.96 | 32.95 | 19.09 | 35.00 |
Columns are period end dates